TokaI raised its consolidated earnings forecast for the fiscal year ending March 2027 and expects record profit on the back of strong performance in its dispensing pharmacy business. Revenue is expected to rise 1.6% from the previous forecast, while profit is expected to increase 12.2–14.5%.
TokaI raised its consolidated earnings forecast for the fiscal year ending March 2027. The strong performance of its dispensing pharmacy business was reflected in higher forecasts for revenue and each profit category.
Under the new forecast, revenue is expected to increase 1.6% from the previous forecast, while operating profit, ordinary profit and net profit, among other profit measures, are expected to rise 12.2–14.5%.
The company aims to set a new record for profit and expects to continue disclosing information on business progress and additional factors.